FDA panel considers a first-of-its-kind flu vaccine using mRNA technology
Moderna seeks FDA approval of its new shot, mFlusvia, as option for 50 and olderUS health advisers are debating a new kind of flu vaccine Thursday, th...
Pessimistic
-43.0